Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Withdrawn NCT07522996

Enarodustat+CsA vs CsA in the Treatment of Newly-diagnosed TD-NSAA

Conditions: Transfusion-dependent Non-severe Aplastic Anemia

Sex: All

Ages: 18 Years – N/A

Healthy volunteers: No

Phase: PHASE3

Sponsor: Peking Union Medical College Hospital

Summary

This study aimed to compare the efficacy and safety of enarodustat combined with cyclosporine versus cyclosporine alone in the treatment of TD-NSAA.

Eligibility Criteria

Inclusion Criteria: 1. Age ≥ 18 years old; 2. Diagnosed with aplastic anemia (AA) through routine blood tests, bone marrow puncture, bone marrow biopsy, and exclusion tests, and determined as transfusion-dependent non-severe aplastic anemia (TD-NSAA) according to the Camitta criteria; Hemoglobin\

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07522996). StuddyBuddy aggregates publicly available trial information.